Table 1 CDX2 expression in relation to clinicopathological characteristics in CRC

Frequencies, n (%)

62 (14.4)

125 (29.0)

244 (56.6)

Sex, n (%)

0.667

 Male

33 (14.3)

63 (27.3)

135 (58.4)

 Female

29 (14.5)

62 (31.0)

109 (54.5)

Age, n (%)

0.275

 ≤59 years

16 (21.1)

18 (23.7)

42 (55.3)

 60–69 years

16 (14.7)

29 (26.6)

64 (58.7)

 70–79 years

20 (12.9)

54 (34.8)

81 (52.3)

 ≥80 years

10 (11.0)

24 (26.4)

57 (62.6)

TNM stage, n (%)^b

<0.001

 I

2 (3.0)

21 (31.8)

43 (65.2)

 II

19 (11.2)

36 (21.3)

114 (67.5)

 III

17 (19.3)

32 (36.4)

39 (44.3)

 IV

24 (24.2)

33 (33.3)

42 (42.4)

Localization, n (%)^b

<0.001

 Right colon

41 (29.5)

27 (19.4)

71 (51.1)

 Left colon

9 (7.1)

39 (30.7)

79 (62.2)

 Rectum

12 (7.5)

59 (36.6)

90 (55.9)

Grade, n (%)^b

<0.001

 Highly to moderately differentiated

13 (6.3)

45 (22.0)

147 (71.7)

 Moderately to poorly differentiated

49 (22.5)

80 (36.7)

89 (40.8)